Effects of beta-blockers on implantable cardioverter defibrillator therapy and survival in the patients with ischemic cardiomyopathy (from the Multicenter Automatic Defibrillator Implantation Trial-II).

No abstract is available for this paper.

• Publication year

  2005

• Venue

  American Journal of Cardiology

• Publication date

  2005-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.AMJCARD.2005.04.046PMID 16125497
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial.

  2005cited by this paper
• &bgr;-Blockers Restore Calcium Release Channel Function and Improve Cardiac Muscle Performance in Human Heart Failure

  2003cited by this paper
• Effect of (cid:1) -Blocking Therapy on Outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT)

  2002cited by this paper
• Concomitant beta-blocker therapy is associated with a lower occurrence of ventricular arrhythmias in patients with decompensated heart failure.

  2002cited by this paper
• PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION

  2002cited by this paper
• Concomitant β-blocker therapy is associated with a lower occurrence of ventricular arrhythmias in patients with decompensated heart failure

  2002cited by this paper
• Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

  2002cited by this paper
• Efficacy of carvedilol on complex ventricular arrhythmias in dilated cardiomyopathy: double-blind, randomized, placebo-controlled study.

  2000cited by this paper
• Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.

  1999cited by this paper
• Metoprolol CR/XL in patients with heart failure: A pilot study examining the tolerability, safety, and effect on left ventricular ejection fraction.

  1999cited by this paper
• The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.

  1999cited by this paper
• Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

  1999cited by this paper
• Importance of beta blockade in the therapy of serious ventricular arrhythmias.

  1998cited by this paper
• Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials.

  1997cited by this paper
• Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials.

  1997cited by this paper
• The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

  1996cited by this paper
• Effect of prophylactic antiarrhythmic therapy on time to implantable cardioverter-defibrillator discharge in patients with ventricular tachyarrhythmias.

  1994cited by this paper
• Beta-blocker therapy in the Cardiac Arrhythmia Suppression Trial. CAST Investigators.

  1994cited by this paper
• Beta-blocker therapy in the cardiac arrhythmia suppression trial

  1994cited by this paper
• Predictors of First Discharge and Subsequent Survival in Patients With Automatic Implantable Cardioverter‐Defibrillators

  1991cited by this paper
• A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results.

  1982cited by this paper

• The Role of Infarct Border Zone Remodelling in Ventricular Arrhythmias: Bridging Basic Research and Clinical Applications

  2025cites this paper
• Evaluation and Management of Arrhythmias in Ischemic Cardiomyopathy.

  2025cites this paper
• The Beta-blocker chronicle: From past principles to present practice – Implications for the Indian subcontinent

  2025cites this paper
• Interference of Atrial Fibrillation with Implantable Cardioverter Defibrillator Therapy in Patients with Heart Failure and Reduced Ejection Fraction

  2023cites this paper
• Quelling the Storm: A Review of the Management of Electrical Storm.

  2023cites this paper
• 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery.

  2022cites this paper
• Expert consensus on acute management of ventricular arrhythmias – VT network Austria

  2021cites this paper
• Sudden cardiac death: epidemiology, pathogenesis and management.

  2021cites this paper
• Association of Guideline-Based Medical Therapy with Malignant Arrhythmias and Mortality among Heart Failure Patients Implanted with Cardioverter Defibrillator (ICD) or Cardiac Resynchronization-Defibrillator Device (CRTD)

  2021cites this paper
• Management of tachyarrhythmias in pregnancy – A review

  2020cites this paper
• Reduced occurrence of appropriate therapy for ventricular arrhythmias after beta-blocker uptitration following implant of a primary prevention CRT-defibrillator

  2020cites this paper
• Clinical Impact of Implantable Cardioverter-Defibrillator Therapy and Mortality Prediction Model for Effective Primary Prevention in Korean Patients

  2020cites this paper
• Beta-blockers as Antiarrhythmic Agents

  2020cites this paper
• Ventricular Arrhythmias

  2020cites this paper
• Health-Related Quality of Life in the Spironolactone to Reduce ICD Therapy (SPIRIT) Trial

  2020cites this paper
• Prospective evaluation of outcome of Indian patients who meet MADIT II (Multicenter Automatic Defibrillator Implantation Trial) criteria for implantable cardioverter defibrillator implantation: is it appropriate for Indian patients?

  2020cites this paper
• Electrical storm: A focused review for the emergency physician.

  2020cites this paper
• Ventricular tachycardia ablation in structural heart disease: Impact of ablation strategy and non-inducibility as an end-point on long term outcome.

  2019cites this paper
• Paciente «estable» con insuficiencia cardiaca: el momento oportuno

  2019cites this paper
• Long‐term follow‐up of implantable cardioverter defibrillator patients with regard to appropriate therapy, complications, and mortality

  2019cites this paper
• Cardiac Arrhythmias and Pregnancy

  2019cites this paper
• Electrical Storm: Current Evidence, Clinical Implications, and Future Perspectives

  2019cites this paper
• Resistant Ventricular Arrhythmia and the Role of Overdrive Pacing in the Suppression of the Electrical Storm

  2019cites this paper
• Anti‐arrhythmic drug therapy in implantable cardioverter‐defibrillator recipients

  2019cites this paper
• Differences in amiodarone efficacy in relation to ejection fraction and basal rhythm in patients with implantable cardioverter defibrillators.

  2018cites this paper
• Advances in pharmacological therapy in reduced left ventricular heart failure patients with implantable cardiac defibrillator and cardiacresynchronization

  2018influential citation
• Beta blockers in patients with end‐stage renal disease—Evidence‐based recommendations

  2018cites this paper
• 22 – Prevention of Sudden Cardiac Death

  2017cites this paper
• Catheter Ablation for Ventricular Tachycardia in Patients with Structural Heart Disease

  2017cites this paper
• Effects of Long-Acting Loop Diuretics in Heart Failure With Reduced Ejection Fraction Patients With Cardiac Resynchronization Therapy.

  2017cites this paper
• Devices for management of sudden cardiac death: Successes, challenges and perspectives.

  2017cites this paper
• Management of ventricular tachycardia storm in patients with structural heart disease

  2017cites this paper
• Do we need further clinical-effectiveness estimates to support the use of primary prevention implantable cardioverter-defibrillators in New York Heart Association class III patients?

  2016cites this paper
• Management of the Electrical Storm in Patients with ICD

  2016cites this paper
• Mortality and predictors of appropriate implantable cardioverter defibrillator therapy in Japanese patients with Multicenter Automatic Defibrillator Implantation Trial II criteria

  2016cites this paper
• Catheter ablation of atrial tachyarrhythmias causing inappropriate implantable cardioverter-defibrillator shocks.

  2015cites this paper
• EHRA/HRS/APHRS expert consensus on ventricular arrhythmias

  2014cites this paper
• Expert consensus recommendations on general diagnostic work-up

  2014cites this paper
• Treatment of ventricular arrhythmias

  2014cites this paper
• EHRA / HRS / APHRS expert consensus on ventricular arrhythmias

  2014cites this paper
• Adjuvant Antiarrhythmic Therapy in Patients with Implantable Cardioverter Defibrillators

  2014cites this paper
• Proarrhythmic Characteristics of Automated Implantable Cardioverter Defi brillators

  2014cites this paper
• EHRA/HRS/APHRS expert consensus on ventricular arrhythmias.

  2014cites this paper
• Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy).

  2013cites this paper
• Clinical Role of Antiarrhythmic Drugs in the Prevention of Sudden Death

  2013cites this paper
• Electrical storm: definitions, clinical importance, and treatment

  2013cites this paper
• Adrenergic Receptor Polymorphisms and Prevention of Ventricular Arrhythmias With Bucindolol in Patients With Chronic Heart Failure

  2013cites this paper
• β1- and α2C-adrenergic receptor polymorphisms and the antiarrhythmic effect of bucindolol in heart failure with reduced ejection fraction.

  2013cites this paper
• Research Highlights: Adrenergic receptor pharmacogenetics in heart failure

  2013cites this paper
• Usefulness of radiofrequency ablation of supraventricular tachycardia to decrease inappropriate shocks from implantable cardioverter-defibrillators.

  2012cites this paper
• Clinical prediction model for death prior to appropriate therapy in primary prevention implantable cardioverter defibrillator patients with ischaemic heart disease: the FADES risk score

  2012cites this paper
• [Updating of the Brazilian guideline for chronic heart failure - 2012].

  2012cites this paper
• Guidelines for Secondary Prevention of Myocardial Infarction (JCS 2011).

  2012cites this paper
• The role of ventricular tachycardia ablation in the reduction of implantable defibrillator shocks.

  2011cites this paper
• Electrical storm: Incidence, Prognosis and Therapy

  2011cites this paper
• PREDICTION OF NON-BENEFIT FROM IMPLANTABLE CARDIOVERTER DEFIBRILLATOR TREATMENT IN PRIMARY PREVENTION PATIENTS WITH ISCHEMIC HEART DISEASE

  2011cites this paper
• Strategies to Reduce ICD Shocks: The Role of Supraventricular Tachycardia–Ventricular Tachycardia Discriminators

  2011cites this paper
• Reducing ICD Shocks for Ventricular Arrhythmias

  2011cites this paper
• Electrical Storm: Incidence, Prognosis and Therapy.

  2011cites this paper
• Clinical experience with a novel subcutaneous implantable defibrillator system in a single center

  2011cites this paper
• The dilemma of implantable cardioverter-defibrillator therapy in the geriatric population

  2011cites this paper
• Relation of ventricular tachycardia/fibrillation to beta-blocker dose maximization guided by pacing mode analysis in nonpacemaker-dependent patients with implantable cardioverter-defibrillator.

  2011cites this paper
• Managing patients with ICD shocks and programming tachycardia therapies during acute heart failure syndromes

  2011cites this paper
• Management of ventricular arrhythmias.

  2010cites this paper
• Management of ventricular tachycardia in patients with structural heart disease.

  2010cites this paper
• Use of implantable cardioverter-defibrillators.

  2010cites this paper
• Underutilization of β-Blockers in Patients Undergoing Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Procedures

  2010cites this paper
• Predictors of Appropriate Implantable Cardioverter Defibrillator (ICD) Therapy in Primary Prevention Patients with Ischemic and Nonischemic Cardiomyopathy

  2010cites this paper
• Implantable cardioverter defibrillator treatment : benefits and pitfalls in the currently indicated population

  2010cites this paper
• β-blockers in the treatment of dilated cardiomyopathy: which is the best?

  2010cites this paper
• Influence of beta-blocker therapy on antitachycardia pacing effectiveness for monomorphic ventricular tachycardias occurring in implantable cardioverter-defibrillator patients: a dose-dependent effect.

  2010cites this paper
• Implantable Cardioverter-Defibrillators

  2010cites this paper
• Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia ablation versus drugs for preventing ICD shocks: role of adjuvant antiarrhythmic drug therapy.

  2009cites this paper
• Treatment of Ventricular Arrhythmias in the Elderly

  2009cites this paper
• Predicting Ventricular Arrhythmias in Patients With Ischemic Heart Disease: Clinical Application of the ECG-Derived QRS-T Angle

  2009cites this paper
• Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock.

  2009cites this paper
• Use of β-Blockers in Patients with an Implantable Cardioverter Defibrillator

  2009cites this paper
• Outcome after device implantation in chronic heart failure is dependent on concomitant medical treatment

  2009cites this paper
• Efficacy of Medical Therapy for the Reduction of Heart Failure Events in Patients with Implanted Cardioverter Defibrillators

  2009cites this paper
• Predictors of appropriate implantable cardioverter-defibrillator therapy during long-term follow-up of patients with coronary artery disease.

  2009cites this paper
• Inappropriate implantable cardioverter-defibrillator therapy: many causes and many possible solutions.

  2009cites this paper
• Implantable device therapy.

  2008cites this paper
• Arrhythmia in Acute Heart Failure

  2008cites this paper
• Long-term follow-up of patients with indication for a implantable defibrillator for primary prevention of death.

  2008cites this paper
• Primary ICD-therapy in patients with advanced heart failure: selection strategies and future trials

  2008cites this paper
• Seguimiento de los pacientes portadores de desfibrilador automático implantable

  2008cites this paper
• Effect of beta blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and statins on mortality in patients with implantable cardioverter-defibrillators.

  2008cites this paper
• Carvedilol in the treatment of elderly patients with chronic heart failure

  2008cites this paper
• Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).

  2008cites this paper
• Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.

  2008cites this paper
• Ventricular arrhythmias in the elderly

  2008cites this paper
• A prospective, randomized, double-blind, placebo controlled trial of beta-blockade in patients who have undergone surgical correction of tetralogy of Fallot

  2007cites this paper
• Primary prevention of sudden cardiac death: apart from the defibrillator, what is important in patients with myocardial infarction or heart failure?

  2007cites this paper
• Implantable cardioverter defibrillators for prevention of sudden cardiac Death

  2007cites this paper
• Adjunctive therapy for recurrent ventricular tachycardia in patients with implantable cardioverter defibrillators

  2007cites this paper
• Sudden death prevention in heart failure: The case of CIBIS III

  2006cites this paper
• Non-arrhythmic therapy of ventricular tachyarrhythmias and sudden cardiac death after acute myocardial infarction.

  2006cites this paper
• Tincture of time: when to implant a prophylactic cardioverter-defibrillator following coronary revascularization?

  2006cites this paper
• Causes and Consequences of Heart Failure After Prophylactic Implantation of a Defibrillator in the Multicenter Automatic Defibrillator Implantation Trial II

  2006cites this paper
• Significance of Inducible Ventricular Flutter‐Fibrillation After Myocardial Infarction

  2005cites this paper